Friday, May 13, 2022
- Advertisement -spot_img


Drug to limit COVID-19 infection

India is working on a drug to contain, limit COVID-19 infection. Click to know

CSIR has decided to develop an approved immunomodulator, Sepsivac, to enhance innate immunity of the body to limit the spread of COVID-19 and fasten the recovery of its patients

Latest news

- Advertisement -spot_img